Deep Dive

GHK-Cu - The Superior Hair Loss Treatment

Everything you need to know about GHK-Cu

FORMULATED BASED ON SCIENTIFIC LITERATURE FROM...

Black and white illustration of a man with a beard and glasses.ScienceDaily logo in black text on a transparent background.Black text logo reading 'healthline' on a transparent background.Smithsonian logo with a sunburst design on the left.ResearchGate logo in black text on a transparent background.
Black and white illustration of a man with a beard and glasses.ScienceDaily logo in black text on a transparent background.Black text logo reading 'healthline' on a transparent background.Smithsonian logo with a sunburst design on the left.ResearchGate logo in black text on a transparent background.

What is GHK-Cu Copper Peptide?

GHK-Cu is a naturally occurring copper-binding peptide that plays a key role in cellular repair and regeneration—especially when it comes to hair loss. In the scalp, it helps stimulate new growth and prevent further hair loss by increasing blood flow (similar to how Minoxidil, or Rogaine, works), reducing inflammation, and activating key genes that support hair follicle repair and growth—such as VEGF and WNT. It also helps counter oxidative stress and DHT-related damage, two major factors of hair loss. By restoring a healthy environment around the follicle, GHK-Cu helps reactivate dormant follicles and support the natural hair growth cycle—without the side effects of conventional drugs.

How was our formula developed?

The story behind Maneup starts in 1973, when GHK-Cu Copper Peptide was first discovered by biochemist Dr. Loren Pickart. Originally identified in human plasma, GHK-Cu was found to play a critical role in wound healing, tissue regeneration, and cellular communication. Early clinical use focused on anti-aging applications— But as more research emerged, scientists began to uncover its application in hair loss.


Over the next several decades, both in vitro and in vivo studies began to highlight GHK-Cu’s powerful impact on hair follicle biology. Research showed that it stimulates angiogenesis, increases vascular endothelial growth factor (VEGF), and downregulates inflammatory markers—all of which are essential for reversing miniaturization of hair follicles. Even more impressively, GHK-Cu has been shown to activate Wnt signaling pathways and upregulate genes involved in hair growth, all without disrupting hormones or causing systemic side effects. Despite the mounting evidence, this promising compound remained largely overlooked by the mainstream hair loss industry.


So we picked up where the research left off and thought, “Why are we still relying on outdated medications with known side effects to treat hair loss?” For decades, the market has been dominated by drugs like finasteride and minoxidil—despite the fact that they are far from the perfect solution.


We didn’t just rely on the old studies—we gathered new data. Our team conducted 12 small-batch production runs, tested different delivery mechanisms and concentrations, and consulted with experts in peptide science, dermatology, and trichology. We evaluated every prototype internally and externally, making sure we had a formula that was absolutely perfect.

What we have created today is a product that is perfectly tailored to the consumer that wants the safest and most effective hair loss solution, but doesn’t want to take traditional hair loss medications that have potential side effects and long term health consequences.

AMAZING!

"Im starting to love the product! Been using it for a few months now and the front of my hairline is really starting to fill in."

NOLAN HYLAND

Professional MMA Fighter

How is our GHK-Cu sourced and made?

Our GHK-Cu is produced through proprietary processes in an FDA registered facility in the United States. This facility is CGMP, and ISO-9001 Certified by the NSF, can you check out our certification here. Each production batch is carefully 3rd party tested for quality and purity which you can review here. Our GHK-Cu is made in partnership with Formu Nova LLC.

Clinical Validation

GHK-Cu has been the subject of extensive clinical research since its discovery in 1973 with the latest studies occurring in 2023, and more planned for the future. Its mechanism of action is well understood, and no evidence in vivo or in vitro suggests it is harmful, toxic, or hormonally disruptive.


In addition to the wealth of clinical research surrounding GHK-Cu, we conducted our own small batch study to evaluate how our formulation compares to conventional treatments. The study involved 25 participants over a five-month period, comparing Maneup’s 0.5% GHK-Cu formula against a control group using 5% Minoxidil. The results spoke for themselves:


  • 75% increase in hair density by month 5 (mean follicle count)

  • 96% of participants saw significant visual improvements and were satisfied with the results

  • 100% reported zero side effects

  • And interestingly, 8% noticed a reduction in gray hairs

These early findings reinforce what the broader scientific literature has already suggested—GHK-Cu isn’t just safe, it works. And when delivered in the right formulation, it can outperform the status quo.

Line graph comparing hair density increase over time for two treatments.

Planned Studies for 2025/2026

  • In vivo Proprietary GHK-Cu encapsulation for enhanced delivery and skin permeability (human)


  • Dissolution


  • In vivo GHK-Cu Proprietary Delivery System Half Life (human)

FAQs